Expression of the ZEB2 gene in pancreatic stromal cells in pancreatic ductal adenocarcinoma, pancreatitis, and normal state

[1]  D. Larsimont,et al.  Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populations , 2011, Oncogene.

[2]  Malte Buchholz,et al.  Stromal biology and therapy in pancreatic cancer , 2010, Gut.

[3]  E. Kopantzev,et al.  Cellular and molecular phenotypes of proliferating stromal cells from human carcinomas , 2010, British Journal of Cancer.

[4]  E. Kopantzev,et al.  Secreted growth factors from stromal fibroblasts of the human lung and pancreatic carcinomas , 2009, Doklady Biological Sciences.

[5]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[6]  G. Berx,et al.  The role of the ZEB family of transcription factors in development and disease , 2009, Cellular and Molecular Life Sciences.

[7]  A. A. Buzdin,et al.  Functional significance of a putative Sp1 transcription factor binding site in the survivin gene promoter , 2008, Biochemistry (Moscow).

[8]  A. Tonevitsky,et al.  Differences in gene expression levels between early and later stages of human lung development are opposite to those between normal lung tissue and non-small lung cell carcinoma. , 2008, Lung cancer.

[9]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[10]  Tatyana Chernova,et al.  Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. , 2007, Molecular biology of the cell.

[11]  M. Reiss,et al.  Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta. , 2007, Experimental cell research.

[12]  H. Kanetake,et al.  Calreticulin Represses E-cadherin Gene Expression in Madin-Darby Canine Kidney Cells via Slug* , 2006, Journal of Biological Chemistry.

[13]  Joan M. Taylor,et al.  Sphingosine 1-Phosphate Stimulates Smooth Muscle Cell Differentiation and Proliferation by Activating Separate Serum Response Factor Co-factors* , 2004, Journal of Biological Chemistry.

[14]  M. Gerretsen,et al.  A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. , 1990, British Journal of Cancer.

[15]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[16]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[17]  Rossiĭskai︠a︡ akademii︠a︡ nauk.  Doklady. Biological sciences , 1964 .